Balcinrenone Shows a Unique Regulation of Potassium Excretion in Streptozotocin-induced Diabetes in Male Mice.
Saved in:
| Title: | Balcinrenone Shows a Unique Regulation of Potassium Excretion in Streptozotocin-induced Diabetes in Male Mice. |
|---|---|
| Authors: | Kanki M; Cardiovascular Endocrinology Laboratory, Discovery & Preclinical Domain, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.; Department of Medicine (Alfred Health), Central Clinical School, Monash University, Prahran, Victoria 3181, Australia., Vivekanantham E; Cardiovascular Endocrinology Laboratory, Discovery & Preclinical Domain, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia., Tesch GH; Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria 3168, Australia., Parslow AC; Baker Heart and Diabetes Institute Microscopy Platform, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.; Baker Department of Cardiometabolic Health, The University of Melbourne, Parkville, Victoria 3052, Australia.; Baker Department Cardiovascular Research, Translation and Implementation, La Trobe University, Bundoora, Victoria 3083, Australia., Cole TJ; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3168, Australia., Fuller PJ; Centre of Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia., Donner DG; Baker Department of Cardiometabolic Health, The University of Melbourne, Parkville, Victoria 3052, Australia.; Preclinical Cardiology Research Group, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia., Kiriazis H; Baker Department of Cardiometabolic Health, The University of Melbourne, Parkville, Victoria 3052, Australia.; Preclinical Cardiology Research Group, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia., de Haan J; Baker Department of Cardiometabolic Health, The University of Melbourne, Parkville, Victoria 3052, Australia.; Cardiovascular Inflammation and Redox Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia., Sun JM; Cardiovascular Endocrinology Laboratory, Discovery & Preclinical Domain, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia., Bamberg K; Early Cardiovascular, Renal, and Metabolism (CVRM) BioPharmaceuticals R&D, AstraZeneca, Gothenburg SE-431 83, Sweden., Young MJ; Cardiovascular Endocrinology Laboratory, Discovery & Preclinical Domain, Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia.; Department of Medicine (Alfred Health), Central Clinical School, Monash University, Prahran, Victoria 3181, Australia.; Baker Department of Cardiometabolic Health, The University of Melbourne, Parkville, Victoria 3052, Australia. |
| Source: | Endocrinology [Endocrinology] 2026 Apr 07; Vol. 167 (5). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print Cited Medium: Internet ISSN: 1945-7170 (Electronic) Linking ISSN: 00137227 NLM ISO Abbreviation: Endocrinology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
